Altium Capital
Overview
Altium Capital Management is a New York-based hedge fund manager focusing on investments in the healthcare industry . Investments are heavily concentrated in US-based small & mid-cap public & private companies with near/medium-term catalysts . The firm prefers to make growth investments in private and public companies operating in the healthcare sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sagimet Biosciences | Feb 2021 | Growth Equity | Co-investor |
| eGenesis | Mar 2021 | Series C | - |
| Skye Bioscience, Inc. | Jan 2024 | Private Placement | Co-investor |
| Aligned Capital | Feb 2022 | Seed | Co-investor |
| Cybin Inc. | Mar 2026 | Private Placement | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Altium Capital based?
Altium Capital is headquartered in New York City, New York, United States.
When was Altium Capital founded?
Altium Capital was founded in 2017.
How many portfolio companies does Altium Capital have?
Altium Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Altium Capital's portfolio?
Portfolio companies visible on Caplight include Sagimet Biosciences, eGenesis, Skye Bioscience, Inc., Aligned Capital, Cybin Inc..
What was Altium Capital's most recent investment shown here?
Altium Capital's most recent investment in this portfolio sample was in Cybin Inc. in 2026.
What sectors does Altium Capital focus on?
Altium Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Altium Capital focus on?
Altium Capital typically invests at the Mid stage.
What is Altium Capital's AUM?
Altium Capital's assets under management are estimated between $50.0M and $100.0M.